BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16116155)

  • 1. First Amsterdam, then Bethesda, now Melbourne?
    Lenz HJ
    J Clin Oncol; 2005 Sep; 23(27):6445-9. PubMed ID: 16116155
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular screening for the Lynch syndrome--better than family history?
    Lynch HT; Lynch PM
    N Engl J Med; 2005 May; 352(18):1920-2. PubMed ID: 15872208
    [No Abstract]   [Full Text] [Related]  

  • 3. Microsatellite instability.
    de la Chapelle A
    N Engl J Med; 2003 Jul; 349(3):209-10. PubMed ID: 12867603
    [No Abstract]   [Full Text] [Related]  

  • 4. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome.
    Dove-Edwin I; de Jong AE; Adams J; Mesher D; Lipton L; Sasieni P; Vasen HF; Thomas HJ
    Gastroenterology; 2006 Jun; 130(7):1995-2000. PubMed ID: 16762622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer: predicting prognosis for patients and probands using immunohistochemistry.
    Khurana V; Stollman N; Rogers AI
    Am J Gastroenterol; 2000 Oct; 95(10):2981-2. PubMed ID: 11051382
    [No Abstract]   [Full Text] [Related]  

  • 6. Current applications of genetic technology in predisposition testing and microsatellite instability assays.
    Frazier ML; Su LK; Amos CI; Lynch PM
    J Clin Oncol; 2000 Nov; 18(21 Suppl):70S-4S. PubMed ID: 11060331
    [No Abstract]   [Full Text] [Related]  

  • 7. On the advent of MSI testing of all colorectal cancers and a substantial part of other Lynch syndrome-related neoplasms.
    Dinjens WN; van Leerdam ME; Wagner A
    Expert Rev Mol Diagn; 2010 May; 10(4):381-4. PubMed ID: 20465492
    [No Abstract]   [Full Text] [Related]  

  • 8. Review article: Detection and management of hereditary non-polyposis colorectal cancer (Lynch syndrome).
    Ramsoekh D; Van Leerdam ME; Wagner A; Kuipers EJ
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():101-11. PubMed ID: 18081654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pathogenesis of colorectal cancer. Foreword.
    Axon AT
    Gastrointest Endosc; 2008 Oct; 68(4 Suppl):S2. PubMed ID: 18805237
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinicopathologic and pedigree differences in amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status.
    Valle L; Perea J; Carbonell P; Fernandez V; Dotor AM; Benitez J; Urioste M
    J Clin Oncol; 2007 Mar; 25(7):781-6. PubMed ID: 17228022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary non-polyposis colon cancer.
    Devlin LA; Price JH; Morrison PJ
    Ulster Med J; 2005 May; 74(1):14-21. PubMed ID: 16025587
    [No Abstract]   [Full Text] [Related]  

  • 12. It is time to get serious about diagnosing Lynch syndrome (hereditary nonpolyposis colorectal cancer with defective DNA mismatch repair) in the general population.
    Terdiman JP
    Gastroenterology; 2005 Aug; 129(2):741-4. PubMed ID: 16083727
    [No Abstract]   [Full Text] [Related]  

  • 13. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?
    Soliman PT; Broaddus RR; Schmeler KM; Daniels MS; Gonzalez D; Slomovitz BM; Gershenson DM; Lu KH
    J Clin Oncol; 2005 Dec; 23(36):9344-50. PubMed ID: 16361634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.
    Macrae F; Harris M
    J Natl Cancer Inst; 2005 Jun; 97(12):936-7; author reply 937-8. PubMed ID: 15956656
    [No Abstract]   [Full Text] [Related]  

  • 15. Underutilization of microsatellite instability analysis in colorectal cancer patients at high risk for Lynch syndrome.
    Van Lier MG; De Wilt JH; Wagemakers JJ; Dinjens WN; Damhuis RA; Wagner A; Kuipers EJ; Van Leerdam ME
    Scand J Gastroenterol; 2009; 44(5):600-4. PubMed ID: 19153873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occult endometrial cancer and decision making for prophylactic hysterectomy in hereditary nonpolyposis colorectal cancer patients.
    Pistorius S; Kruger S; Hohl R; Plaschke J; Distler W; Saeger HD; Schackert HK
    Gynecol Oncol; 2006 Aug; 102(2):189-94. PubMed ID: 16476474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic testing for inherited susceptibility of colorectal cancer: part II. Hereditary nonpolyposis colorectal cancer (HNPCC).
    Tecnologica MAP Suppl; 1998 Feb; ():10-5. PubMed ID: 10183352
    [No Abstract]   [Full Text] [Related]  

  • 18. New developments in Lynch syndrome (hereditary nonpolyposis colorectal cancer) and mismatch repair gene testing.
    Gruber SB
    Gastroenterology; 2006 Feb; 130(2):577-87. PubMed ID: 16472609
    [No Abstract]   [Full Text] [Related]  

  • 19. Who should be sent for genetic testing in hereditary colorectal cancer syndromes?
    Lynch HT; Boland CR; Rodriguez-Bigas MA; Amos C; Lynch JF; Lynch PM
    J Clin Oncol; 2007 Aug; 25(23):3534-42. PubMed ID: 17687158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsatellite instability in colorectal cancer.
    Heinimann K; Müller H; Dobbie Z
    N Engl J Med; 2000 May; 342(21):1607-8. PubMed ID: 10841678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.